[Patient with hypoplastic leukemia successfully treated with N4-palmitoyl-1-beta-D-arabinofuranosyl cytosine]. 1985

M Uchida, and H Tsutani, and D Kagawa, and T Ueda, and N Domae, and T Nakamura

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008297 Male Males
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M Uchida, and H Tsutani, and D Kagawa, and T Ueda, and N Domae, and T Nakamura
April 1988, Gan to kagaku ryoho. Cancer & chemotherapy,
M Uchida, and H Tsutani, and D Kagawa, and T Ueda, and N Domae, and T Nakamura
May 1992, International journal of cancer,
M Uchida, and H Tsutani, and D Kagawa, and T Ueda, and N Domae, and T Nakamura
February 1983, Gan to kagaku ryoho. Cancer & chemotherapy,
M Uchida, and H Tsutani, and D Kagawa, and T Ueda, and N Domae, and T Nakamura
February 1984, Nihon Gan Chiryo Gakkai shi,
M Uchida, and H Tsutani, and D Kagawa, and T Ueda, and N Domae, and T Nakamura
January 1971, Clinical pharmacology and therapeutics,
M Uchida, and H Tsutani, and D Kagawa, and T Ueda, and N Domae, and T Nakamura
March 1966, Journal of medicinal chemistry,
M Uchida, and H Tsutani, and D Kagawa, and T Ueda, and N Domae, and T Nakamura
March 1996, [Rinsho ketsueki] The Japanese journal of clinical hematology,
M Uchida, and H Tsutani, and D Kagawa, and T Ueda, and N Domae, and T Nakamura
January 1986, Cancer chemotherapy and pharmacology,
M Uchida, and H Tsutani, and D Kagawa, and T Ueda, and N Domae, and T Nakamura
December 1988, [Rinsho ketsueki] The Japanese journal of clinical hematology,
M Uchida, and H Tsutani, and D Kagawa, and T Ueda, and N Domae, and T Nakamura
January 1979, Nucleic acids symposium series,
Copied contents to your clipboard!